AAD 2026Abstract 74494
Designing a secukinumab dosing regimen in adolescents with moderate to severe hidradenitis suppurativa using model-informed drug development
Bieth B, Renard D, Bruin G, Martin R, Martinez AL, Zharkov A, Chuc T, Mendelson M
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Hidradenitis suppurativaPediatric dermatology
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.602 · Not in PubMed: details from Crossref